| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.28 | 0.05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |